Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?

10mon ago, source: Hosted on MSN

Is Anebulo Pharmaceuticals, Inc. (ANEB) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Anebulo Pharmaceuticals, Inc. is a member of ...

Anebulo Pharmaceuticals Inc ANEB

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Down -26.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Anebulo Pharmaceuticals, Inc. (ANEB)

11mon ago, source: Hosted on MSN

A downtrend has been apparent in Anebulo Pharmaceuticals, Inc. (ANEB) lately with too much selling pressure. The stock has declined 26.4% over the past four weeks. However, given the fact that it ...

ANTX AN2 Therapeutics, Inc.

14d ago, source: Seeking Alpha

It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize, or otherwise exploit certain compounds and products, including epetraborole, for the ...

CGTX Cognition Therapeutics, Inc.

2d ago, source: Seeking Alpha

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and ...

Madrigal Pharmaceuticals, Inc. (MDGL)

2d ago, source: Yahoo Finance

CONSHOHOCKEN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its first-quarter 2024 financial results on Tuesday ...

Anebulo Pharmaceuticals Inc ANEB

15d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Anebulo Pharmaceuticals Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Anebulo Pharmaceuticals Inc (ANEB)

2mon ago, source: Investing

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) ...